Cargando…

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673036/ https://www.ncbi.nlm.nih.gov/pubmed/29184424 http://dx.doi.org/10.2147/DMSO.S154662

Ejemplares similares

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
por: Irons, Brian K, et al.
Publicado: (2014)

Corrigendum: Hemorheologic Alterations in Patients with Type 2 Diabetes Mellitus Presented with an Acute Myocardial Infarction
por: Park, Kyu-Hwan, et al.
Publicado: (2018)

Corrigendum: Author ORCID Number Correction. Dietary Sodium Intake in Patients with Type 2 Diabetes Mellitus
por: Kim, Mi-Kyung
Publicado: (2017)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
Publicado: (2019)

Corrigendum to “The Impact of Type 2 Diabetes Mellitus on Long-Term Prognosis in Patients of Different Ages with Myocardial Infarction”
por: Afanasiev, S. A., et al.
Publicado: (2019)

Corrigendum to “Impact of Diabetic Ketoacidosis on Thyroid Function in Patients with Diabetes Mellitus”
por: Xing, Yuling, et al.
Publicado: (2021)

Corrigendum to “Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus”
por: Tang, Ruiqi, et al.
Publicado: (2021)

Corrigendum to “Correlation between lower extremity arterial disease and skeletal muscle mass in patients with type 2 diabetes mellitus”
Publicado: (2020)

Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
por: Ruiz-Tamayo, Irene, et al.
Publicado: (2016)

Corrigendum: Table and Text Correction. Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians
por: Iqbal, Ahmed, et al.
Publicado: (2018)

Corrigendum to “Effect of Intervention in Subjects with High Risk of Diabetes Mellitus in Pakistan”
por: Hydrie, Muhammad Zafar Iqbal, et al.
Publicado: (2015)

Polysaccharide Peptide (PsP) Ganoderma lucidum: A Potential Inducer For Vascular Repair In Type 2 Diabetes Mellitus Model [Corrigendum]
Publicado: (2019)

Corrigendum to “Pancreatic Function, Type 2 Diabetes, and Metabolism in Aging”
por: Gong, Zhenwei, et al.
Publicado: (2017)

Corrigendum to “Diabetes Remission after Nonsurgical Intensive Lifestyle Intervention in Obese Patients with Type 2 Diabetes”
por: Mottalib, Adham, et al.
Publicado: (2016)

Corrigendum to “Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes”
por: Fu, Yuanyuan, et al.
Publicado: (2022)

Association of ADIPOQ Single-Nucleotide Polymorphisms with the Two Clinical Phenotypes Type 2 Diabetes Mellitus and Metabolic Syndromein a Kinh Vietnamese Population [Corrigendum]
Publicado: (2022)

Corrigendum to “Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran” [Data in Brief 18 (2018) 2047–2050]
por: Mostafavian, Zahra, et al.
Publicado: (2018)

Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer [Corrigendum]
Publicado: (2020)

Non-Pharmacologic Approach to Prevent Embolization in Patients with Atrial Fibrillation in Whom Anticoagulation is Contraindicated
por: Sharma, Munish, et al.
Publicado: (2017)

Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences”
por: Russo, Giuseppina T., et al.
Publicado: (2017)

Detection of neuropathy using a sudomotor test in type 2 diabetes [Corrigendum]
Publicado: (2015)

Corrigendum to “Hypoglycemic Activity through a Novel Combination of Fruiting Body and Mycelia of Cordyceps militaris in High-Fat Diet-Induced Type 2 Diabetes Mellitus Mice”
por: Yu, Sung-Hsun, et al.
Publicado: (2017)

A Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of LiuWei DiHuang Pill in Treating Type 2 Diabetes Mellitus [Corrigendum]
por: He, Dan, et al.
Publicado: (2020)

Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis
Publicado: (2023)

Corrigendum to “A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes”
por: Hassani-Ardakani, Kimya, et al.
Publicado: (2021)

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes [Corrigendum]
Publicado: (2014)

Corrigendum to: Anti‐aging pharmacology in cutaneous wound healing: Effects of metformin, resveratrol, and rapamycin by local application
Publicado: (2022)

Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”
por: Xie, Yijun, et al.
Publicado: (2018)

Corrigendum to “Islet β-Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest”
por: Mellado-Gil, Jose Manuel, et al.
Publicado: (2019)

Corrigendum to “Ameliorative Effect of Saffron Aqueous Extract on Hyperglycemia, Hyperlipidemia, and Oxidative Stress on Diabetic Encephalopathy in Streptozotocin Induced Experimental Diabetes Mellitus”
por: International, BioMed Research
Publicado: (2020)

Association between patients’ beliefs and oral antidiabetic medication adherence in a Chinese type 2 diabetic population [Corrigendum]
Publicado: (2016)

Corrigendum to: Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Publicado: (2022)

Corrigendum to Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial
Publicado: (2023)

Corrigendum to “Protective Effect of Ginkgo biloba and Magnetized Water on Nephropathy in Induced Type 2 Diabetes in Rat”
por: Zayed, Ahmed E., et al.
Publicado: (2018)

Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]
Publicado: (2016)

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges [Corrigendum]
Publicado: (2021)

Resveratrol Prevents Cognitive Impairment in Type 2 Diabetic Mice by Upregulating Nrf2 Expression and Transcriptional Level [Corrigendum]
Publicado: (2020)

Corrigendum to “Five-Year Incidence and Progression of Diabetic Retinopathy in Patients with Type II Diabetes in a Tertiary Care Center in Lebanon”
por: Mehanna, Carl-Joe, et al.
Publicado: (2018)

Corrigendum to “Osteoporosis, Fractures, and Diabetes”
por: Jackuliak, Peter, et al.
Publicado: (2017)

Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4s6l2jfbrt66dr75jp17qcrkkb